Some studies have highlighted psychological and neuropsychological difficulties and a potential reduction in health-related quality of life (HRQOL) in patients with pituitary tumors, despite hormone deficits or excess. To the authors' knowledge, this study is the first prospective longitudinal case-control study with the aim of simultaneously testing whether HRQOL and psychiatric and neuropsychological disabilities are related to neural dysfunction due to hypercortisolism per se, or tumor mass and/or surgery in patients with Cushing's disease (CD). The authors evaluated a homogeneous cohort of patients with CD and nonfunctioning pituitary adenomas (NFPAs) before and after neurosurgery and compared these patients with healthy controls.
Cushing's disease: a prospective case-control study of health-related quality of life and cognitive status before and after surgery / Zarino, Barbara; Verrua, Elisa; Ferrante, Emanuele; Sala, Elisa; Carosi, Giulia; Giavoli, Claudia; Serban, Andreea L; Del Sindaco, Giulia; Sirtori, Martina A; Bertani, Giulio A; Rampini, Paolo; Carrabba, Giorgio G; Arosio, Maura; Spada, Anna; Locatelli, Marco; Mantovani, Giovanna. - In: JOURNAL OF NEUROSURGERY. - ISSN 0022-3085. - (2019), pp. 1-11. [10.3171/2019.8.JNS19930]
Cushing's disease: a prospective case-control study of health-related quality of life and cognitive status before and after surgery
Carosi, GiuliaData Curation
;Serban, Andreea LWriting – Original Draft Preparation
;
2019
Abstract
Some studies have highlighted psychological and neuropsychological difficulties and a potential reduction in health-related quality of life (HRQOL) in patients with pituitary tumors, despite hormone deficits or excess. To the authors' knowledge, this study is the first prospective longitudinal case-control study with the aim of simultaneously testing whether HRQOL and psychiatric and neuropsychological disabilities are related to neural dysfunction due to hypercortisolism per se, or tumor mass and/or surgery in patients with Cushing's disease (CD). The authors evaluated a homogeneous cohort of patients with CD and nonfunctioning pituitary adenomas (NFPAs) before and after neurosurgery and compared these patients with healthy controls.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.